| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | Common Stock | Options Exercise | $0 | +2,500 | +20% | $0.000000 | 14,784 | 01 Mar 2023 | Direct | |
| transaction | CNMD | Common Stock | Tax liability | $70,774 | -736 | -5% | $96.16 | 14,048 | 01 Mar 2023 | Direct | |
| transaction | CNMD | Common Stock | Options Exercise | $323,784 | +5,400 | +38% | $59.96 | 19,448 | 02 Mar 2023 | Direct | |
| transaction | CNMD | Common Stock | Sale | $519,723 | -5,400 | -28% | $96.24 | 14,048 | 02 Mar 2023 | Direct | |
| transaction | CNMD | Common Stock | Options Exercise | $393,800 | +5,000 | +36% | $78.76 | 19,048 | 02 Mar 2023 | Direct | |
| transaction | CNMD | Common Stock | Sale | $480,381 | -5,000 | -26% | $96.08 | 14,048 | 02 Mar 2023 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CNMD | Rsus (restricted Stock Units) | Options Exercise | $0 | -2,500 | -100% | $0.000000* | 0 | 01 Mar 2023 | Common Stock | 2,500 | $0.000000 | Direct | F2 |
| transaction | CNMD | Rsus (restricted Stock Units) | Award | $0 | +3,000 | $0.000000 | 3,000 | 01 Mar 2023 | Common Stock | 3,000 | $0.000000 | Direct | F3 | |
| transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -5,400 | -100% | $0.000000* | 0 | 02 Mar 2023 | Common Stock | 5,400 | $59.96 | Direct | F4 |
| transaction | CNMD | Options To Purchase Common Stock | Options Exercise | $0 | -5,000 | -50% | $0.000000 | 5,000 | 02 Mar 2023 | Common Stock | 5,000 | $78.76 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.03 to $96.24. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| F2 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting 100% after a one year period. |
| F3 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting in equal amounts (1000 units) over a three year period. |
| F4 | The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
| F5 | The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |